Hudson Bay Capital Management LP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,319,000
+1504.8%
550,000
+3566.7%
0.04%
+800.0%
Q2 2023$705,300
-86.9%
15,000
-88.3%
0.01%
-79.2%
Q1 2023$5,398,406
-51.2%
128,656
-55.6%
0.02%
-78.8%
Q4 2022$11,060,600
-4.3%
290,000
-1.7%
0.11%
+10.8%
Q3 2022$11,552,000
+21.2%
295,0000.0%0.10%
+41.7%
Q2 2022$9,529,000
+539.5%
295,000
+555.6%
0.07%
+260.0%
Q1 2022$1,490,000
-29.9%
45,000
-10.0%
0.02%
-9.1%
Q4 2021$2,127,000
+92.0%
50,000
+100.0%
0.02%
+46.7%
Q3 2021$1,108,000
-82.2%
25,000
-83.3%
0.02%
-86.2%
Q2 2020$6,237,000
+141.3%
150,000
+66.7%
0.11%
+67.7%
Q1 2020$2,585,000
+84.2%
90,000
+800.0%
0.06%
+66.7%
Q3 2019$1,403,000
-23.4%
10,0000.0%0.04%
-7.1%
Q2 2019$1,831,000
-42.4%
10,000
-50.0%
0.04%
+2.4%
Q1 2019$3,181,000
+66.0%
20,0000.0%0.04%
+57.7%
Q4 2018$1,916,000
+207.5%
20,000
+100.0%
0.03%
+73.3%
Q3 2017$623,00010,0000.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders